RecruitingPhase 3NCT06498635Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialSponsor: National Cancer Institute (NCI)Chicago, IL · DeKalb, IL · Geneva, IL · +278 more sites
RecruitingPhase 2NCT06031688Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)Sponsor: SWOG Cancer Research NetworkBloomington, IL · Canton, IL · Carthage, IL · +275 more sites
RecruitingPhase 3NCT06686771Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung CancerSponsor: Canadian Cancer Trials GroupAlton, IL · Chicago, IL · Decatur, IL · +68 more sites
RecruitingPhase 2NCT05642572Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)Sponsor: SWOG Cancer Research NetworkBarrington, IL · Bloomington, IL · Canton, IL · +451 more sites
RecruitingPhase 2 / Phase 3NCT03851445Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerSponsor: SWOG Cancer Research NetworkAlton, IL · Aurora, IL · +1226 more sites
RecruitingPhase 2NCT06769126Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM StudySponsor: SWOG Cancer Research NetworkChicago, IL · DeKalb, IL · Geneva, IL · +145 more sites